IUScholarWorks at Indiana University South Bend Engineering Synthetic Antibody Binders for Allosteric Inhibition of Prolactin Receptor Signaling
暂无分享,去创建一个
Anna Szymborska | A. Kossiakoff | S. Mukherjee | Shahir S. Rizk | C. Clevenger | Jiamao Zheng | E. Duguid | J. Kouadio
[1] A. Kossiakoff,et al. Allosteric Control of Ligand Binding Affinity Using Engineered Conformation-Specific Effector Proteins , 2010, Nature Structural &Molecular Biology.
[2] Patrick England,et al. Structural characterization of the stem-stem dimerization interface between prolactin receptor chains complexed with the natural hormone. , 2010, Journal of molecular biology.
[3] Patrick England,et al. Crystal Structure of an Affinity-matured Prolactin Complexed to Its Dimerized Receptor Reveals the Topology of Hormone Binding Site 2* , 2010, The Journal of Biological Chemistry.
[4] S. Gadd,et al. New mechanisms for PRLr action in breast cancer , 2009, Trends in Endocrinology & Metabolism.
[5] C. Clevenger,et al. Quantification of PRL/Stat5 signaling with a novel pGL4-CISH reporter , 2008, BMC biotechnology.
[6] Frederic A. Fellouse,et al. High-throughput generation of synthetic antibodies from highly functional minimalist phage-displayed libraries. , 2007, Journal of molecular biology.
[7] Anthony A Kossiakoff,et al. Crystal structure and site 1 binding energetics of human placental lactogen. , 2006, Journal of molecular biology.
[8] S. Hankinson,et al. The role of prolactin in mammary carcinoma. , 2003, Endocrine reviews.
[9] M. Krieger,et al. Series introduction: multiligand receptors and human disease. , 2001, The Journal of clinical investigation.
[10] M. Ultsch,et al. The X-ray structure of a growth hormoneprolactin receptor complex , 1994, Nature.
[11] S. Bass,et al. Zinc mediation of the binding of human growth hormone to the human prolactin receptor. , 1990, Science.
[12] F. Schmitz,et al. Expression of functional prolactin and its receptor in human colorectal cancer , 2002, International Journal of Colorectal Disease.